Reprieve Cardiovascular last Saturday released results from two trials of its Reprieve-Guided diuretic therapy exploring its use in treating patients hospitalized with acute heart failure, touting that the system allows for safe decongestion. Results from the trials were presented at the Heart Failure 2019 Congress in Athens, Greece, the Milford, Mass.-based company said. Reprieve Cardiovascular said […]
reprievecardiovascular
Reprieve Cardiovascular touts early ADHF therapy study data
Reprieve Cardiovascular this week released early study results from the Target II study of its Reprieve-Guided Diuretic Therapy intended to improve fluid management for patients with acute decompensated heart failure, touting improvements in fluid management optimization. Early data from the study were presented by study investigator Dr. Piotr Ponikowski of Wroclaw Medical University at the […]
Abiomed gets in on $7m round for RenalGuard affiliate Reprieve Cardiovascular
RenalGuard Solutions said today it closed a $7 million financing round joined by Abiomed (NSDQ:ABMD) to support its newly formed affiliate company Reprieve Cardiovascular. Milford, Mass.-based Reprieve Cardiovascular said that it is developing devices intended for patients suffering from acute decompensated heart failure. The technology is part of the company’s Guided Diuretic Therapy, which is being investigated as a […]